Annie Hazlehurst is the founder of Faridan. Annie loves working with people who have the courage to create change. Born and raised in Silicon Valley, she was once a bioengineer with a fascination in complexity theory and believes that emerging intersections of genomics and artificial intelligence will transform medicine.
Over the years, she has lived in the African bush, rural and urban Asia, and a modern Middle East all of which have solidified her commitment to working with entrepreneurs addressing the hard problems, the ones bringing technical innovation to a global community.
Annie currently serves on the Board of Emerald Cloud Lab, Arbor Biotechnologies and Aceso Global. Previously, she served on the Board of Human Longevity, Inc. and Gro Intelligence. Back in the day, she was an Investment Banking Analyst at Morgan Stanley before joining Draper Fisher Jurvetson (DFJ) to focus on early stage technology investments in a wide array of emerging areas from synthetic biology and advanced materials to intelligent software. She has spent time working with Capricorn Investment Group, Mubadala Development Company and the IFC.
Annie graduated Magna Cum Laude from Brown University with a BS in Bioengineering. She holds an MS Environment and Resources from Stanford University and an MBA from the Stanford Graduate School of Business.
Currently, Annie calls New York City home, but her horse lives in California and her suitcase is never unpacked. Her friends insist she’s an international person of mystery.